Roniscan
Roniscan
Generic Name: Gadodiamide
Pharmacologic Category: Radiological/Contrast Media (Nonionic, Low Osmolality)
Dosage Form and Strengths: 287 mg/mL (10 mL) solution in a vial for injection
Indications: Roniscan is a gadolinium-based contrast agent indicated for intravenous use in MRI to visualize lesions with abnormal vascularity within the thoracic (noncardiac), abdominal, pelvic cavities, and retroperitoneal space (Body imaging) and also lesions with abnormal vascularity in the brain, spine, and associated tissues (CNS imaging).
- Supporting the health of patients
- Approved by the Ministry of Health
- Sufficient and proper distribution
- Quality assurance of medicine
Description
Generic Name: Gadodiamide
Pharmacologic Category: Radiological/Contrast Media (Nonionic, Low Osmolality)
Dosage Form and Strengths: 287 mg/mL (10 mL) solution in a vial for injection
Indications: Roniscan is a gadolinium-based contrast agent indicated for intravenous use in MRI to visualize lesions with abnormal vascularity within the thoracic (noncardiac), abdominal, pelvic cavities, and retroperitoneal space (Body imaging) and also lesions with abnormal vascularity in the brain, spine, and associated tissues (CNS imaging).